Findling, Robert L.
Virginia Commonwealth University · Virginia Commonwealth University Medical Center
57 papers on CoChatORCID 0000-0002-7654-5782
Most cited papers
- Verified
Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity
Kemp, D. E., Ismail-Beigi, F., Ganocy, S. J., Conroy, C., Gao, K., Obral, S., Fein, E., Findling, R. L., & Calabrese, J. R. (2012) · Journal of Affective Disorders
Treatment of Major DepressionTryptophan and brain disorders
Cited by 109
- Verified
A 6-Month, Double-Blind, Maintenance Trial of Lithium Monotherapy Versus the Combination of Lithium and Divalproex for Rapid-Cycling Bipolar Disorder and Co-Occurring Substance Abuse or Dependence
Kemp, D. E., Gao, K., Ganocy, S. J., Elhaj, O., Bilali, S. R., Conroy, C., Findling, R. L., & Calabrese, J. R. (2009) · The Journal of Clinical Psychiatry
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 103
- Verified
Double-Blind Maintenance Safety and Effectiveness Findings From the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) Study
Findling, R. L., Johnson, J. L., McClellan, J., Frazier, J. A., Vitiello, B., Hamer, R. M., Lieberman, J. A., Ritz, L., McNamara, N. K., Lingler, J., et al. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry
Schizophrenia research and treatmentBipolar Disorder and Treatment
Cited by 101
- Verified
Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6–12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial
Connor, D. F., Findling, R. L., Kollins, S. H., Sallee, F., López, F. A., Lyne, A., & Tremblay, G. (2010) · CNS Drugs
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 101
- Verified
Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS): Rationale, Design, and Methods
McCLELLAN, J., SIKICH, L., FINDLING, R. L., FRAZIER, J. A., VITIELLO, B., HLASTALA, S. A., WILLIAMS, E., AMBLER, D., HUNT-HARRISON, T., MALONEY, A. E., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry
Schizophrenia research and treatmentBipolar Disorder and Treatment
Cited by 90
- Verified
Long-Term Effectiveness and Safety of Lisdexamfetamine Dimesylate in School-Aged Children with Attention-Deficit/Hyperactivity Disorder
Findling, R. L., Childress, A. C., Krishnan, S., & McGough, J. J. (2008) · CNS Spectrums
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 90
- Verified
Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates
Freeman, A. J., Youngstrom, E. A., Youngstrom, J. K., & Findling, R. L. (2016) · Journal of Child and Adolescent Psychopharmacology
Child and Adolescent Psychosocial and Emotional DevelopmentPersonality Disorders and Psychopathology
Cited by 84
- Verified
Comorbidities in adult attention-deficit/hyperactivity disorder: a practical guide to diagnosis in primary care
Mao, A. R., & Findling, R. L. (2014) · Postgraduate Medicine
Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes
Cited by 68
- Verified
The Relevance of Pharmacokinetic Studies in Designing Efficacy Trials in Juvenile Major Depression
Findling, R. L., McNamara, N. K., Stansbrey, R. J., Feeny, N. C., Young, C. M., Peric, F. V., & Youngstrom, E. A. (2006) · Journal of Child and Adolescent Psychopharmacology
Treatment of Major DepressionPharmaceutical studies and practices
Cited by 64
- Verified
Concerns Regarding the Inclusion of Temper Dysregulation Disorder With Dysphoria in the Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition: (Commentary)
Axelson, D. A., Birmaher, B., Findling, R. L., Fristad, M. A., Kowatch, R. A., Youngstrom, E. A., Arnold, L. E., Goldstein, B. I., Goldstein, T. R., Chang, K. D., et al. (2011) · The Journal of Clinical Psychiatry
Child and Adolescent Psychosocial and Emotional DevelopmentPersonality Disorders and Psychopathology
Cited by 62
- Verified
A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD
Johnson, J. K., Liranso, T., Saylor, K., Tulloch, G., Adewole, T., Schwabe, S., Nasser, A., Findling, R. L., & Newcorn, J. H. (2020) · Journal of Attention Disorders
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 62
- Verified
Escitalopram in the Treatment of Adolescent Depression: A Randomized, Double-Blind, Placebo-Controlled Extension Trial
Findling, R. L., Robb, A., & Bose, A. (2013) · Journal of Child and Adolescent Psychopharmacology
Treatment of Major DepressionChild and Adolescent Psychosocial and Emotional Development
Cited by 57
- Verified
Effects of Once-Daily Oral and Transdermal Methylphenidate on Sleep Behavior of Children With ADHD
Faraone, S. V., Glatt, S. J., Bukstein, O. G., Lopez, F. A., Arnold, L. E., & Findling, R. L. (2009) · Journal of Attention Disorders
Attention Deficit Hyperactivity DisorderSleep and related disorders
Cited by 56
- Verified
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status
Findling, R. L., Candler, S. A., Nasser, A. F., Schwabe, S., Yu, C., Garcia-Olivares, J., O’Neal, W., & Newcorn, J. H. (2021) · CNS Drugs
Attention Deficit Hyperactivity DisorderTreatment of Major Depression
Cited by 55
- Verified
Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial
Findling, R. L., Landbloom, R. L., Mackle, M., Wu, X., Snow-Adami, L., Chang, K., & Durgam, S. (2016) · Pediatric Drugs
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 53
- Verified
Effectiveness, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Optimization Study
Findling, R. L., Ginsberg, L. D., Jain, R., & Gao, J. (2009) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 47
- Verified
Paediatric uses of atypical antipsychotics
Findling, R. L., McNamara, N. K., & Gracious, B. L. (2000) · Expert Opinion on Pharmacotherapy
Schizophrenia research and treatmentPharmaceutical studies and practices
Cited by 46
- Verified
Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design
Brams, M., Weisler, R., Findling, R. L., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Squires, L. (2012) · The Journal of Clinical Psychiatry
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 41
- Verified
A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
Findling, R. L., Cutler, A. J., Saylor, K., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Childress, A. C. (2013) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 40
- Verified
Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study
Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., Galil, N., Kaplan, S., Busner, J., Nilsson, M. E., Brown, E. B., & Jacobson, J. G. (2006) · Journal of Child and Adolescent Psychopharmacology
Treatment of Major DepressionChild and Adolescent Psychosocial and Emotional Development
Cited by 39
- Verified
Demographic and clinical correlates of autism symptom domains and autism spectrum diagnosis
Frazier, T. W., Youngstrom, E. A., Embacher, R., Hardan, A. Y., Constantino, J. N., Law, P., Findling, R. L., & Eng, C. (2014) · Autism
Autism Spectrum Disorder ResearchChild Nutrition and Feeding Issues
Cited by 39
- Verified
Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder
Findling, R. L., McBurnett, K., White, C., & Youcha, S. (2014) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 32
- Verified
Toward prevention of bipolar disorder in at-risk children: Potential strategies ahead of the data
Post, R. M., Goldstein, B. I., Birmaher, B., Findling, R. L., Frey, B. N., DelBello, M. P., & Miklowitz, D. J. (2020) · Journal of Affective Disorders
Bipolar Disorder and TreatmentPersonality Disorders and Psychopathology
Cited by 31
- Verified
A Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled, Dose-Optimization Study of the Methylphenidate Transdermal System for the Treatment of ADHD in Adolescents
Findling, R. L., Turnbow, J., Burnside, J., Melmed, R., Civil, R., & Li, Y. (2010) · CNS Spectrums
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free